Online first articles
Articles not assigned to an issue 21 articles
-
-
Group-Based Trajectory Modeling of Fluid Balance in Elderly Patients with Acute Ischemic Stroke: Analysis from Multicenter ICUs
Authors
- Jia Tang
- Changdong Wu
- Zhenguang Zhong
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 18 April 2024
-
Chinese Translation and Validation of the Center for Neurologic Study Lability Scale
Authors (first, second and last of 12)
- Lu Chen
- Shan Ye
- Dongsheng Fan
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 16 April 2024
-
Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study
Authors (first, second and last of 12)
- Xiao Zhang
- Xinzhi Hu
- Tao Wang
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 15 April 2024
-
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study
Authors (first, second and last of 6)
- Xiao-Na Ma
- Wei Feng
- Qiang Xu
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 09 April 2024
-
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis
Authors (first, second and last of 9)
- Jerome de Seze
- Dominique Dive
- Chiara Zecca
- Content type: REVIEW
- Open Access
- Published: 08 April 2024
-
Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial
Authors (first, second and last of 6)
- Shoichiro Sato
- Naohisa Hatakeyama
- John R. Sims
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 06 April 2024
-
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study
Authors (first, second and last of 6)
- Takao Takeshima
- Hikaru Doi
- Mika Komori
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 06 April 2024
-
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
Authors (first, second and last of 16)
- Samuel Frank
- Karen E. Anderson
- Maria Chen
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 01 April 2024
-
Anti-N-methyl-d-aspartate Receptor Encephalitis in People Living with HIV: Case Report and Literature Review
Authors (first, second and last of 7)
- Jiangjin Hui
- Jinhua Wang
- Biao Zhu
- Content type: CASE SERIES
- Open Access
- Published: 26 March 2024
-
REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program
Authors (first, second and last of 8)
- Matthias Schwab
- Andrew Chan
- Christoph Grothe
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 26 March 2024
-
Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study
Authors (first, second and last of 10)
- Marco Luigetti
- Dianna Quan
- David Adams
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 21 March 2024
-
Publisher Correction: Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
Authors (first, second and last of 4)
- Sarah A. Morrow
- Paola Kruger
- Nektaria Alexandri
- Content type: Publisher Correction
- Open Access
- Published: 19 March 2024
This is part of 1 collection: -
Correction: Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
Authors
- Angelo Ghezzi
- R. F. Neuteboom
- Content type: Correction
- Open Access
- Published: 18 March 2024
-
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France
Authors (first, second and last of 8)
- Jonathan Ciron
- Bertrand Bourre
- Patrick Vermersch
- Content type: REVIEW
- Open Access
- Published: 15 March 2024
-
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study
Authors (first, second and last of 33)
- Piero Barbanti
- Gabriella Egeo
- for the Italian Migraine Registry study group
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 07 March 2024
-
Impact of Immune Cells on Stroke Limited to Specific Subtypes: Evidence from Mendelian Randomization Study
Authors (first, second and last of 6)
- Chen Chen
- Qi Liu
- Li Liu
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 06 March 2024
-
Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey
Authors (first, second and last of 5)
- Mary A. Curry
- Rosángel E. Cruz
- Jill Jarecki
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 02 March 2024
-
Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG
Authors (first, second and last of 13)
- Feng Liang
- Zhaoxu Yin
- Wei Zhang
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 01 March 2024
-
The Association Between National Institutes of Health Stroke Scale Score and Clinical Outcome in Patients with Large Core Infarctions Undergoing Endovascular Treatment
Authors (first, second and last of 12)
- Lingyu Zhang
- Jinfu Ma
- Pengfei Wang
- Content type: ORIGINAL RESEARCH
- Open Access
- Published: 01 March 2024
-
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
Authors (first, second and last of 4)
- Sarah A. Morrow
- Paola Kruger
- Nektaria Alexandri
- Content type: SUMMARY OF RESEARCH
- Open Access
- Published: 20 February 2024
This is part of 2 collections:
For authors
Submit manuscriptWorking on a manuscript?
Avoid the most common mistakes and prepare your manuscript for journal editors.
Learn more